NSB Market Cap $ 23 million Very well Funded Option Expiry this week .
Safety and Toxicity Report to be completed and to be reported this quarter and to Commence Phase 1 next quarter .
Great Interview at Stock Head , definitely a salesman which is extremely important in small caps early on to generate interest. Safety and Toxicity as well as Phase 1 studies are going to be conservative with a small cohort of Patients .Phase 2a, 2b is where its get much more difficult as your dealing with a larger cohort of patients , dosages , patients with different levels of damage , demographics , etc . It is completely different in terms of risk as an investor or trader .
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 01 Mar
Short Term Trading Week Starting: 01 Mar, page-25
-
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online